ASCO Not What Your Biotechs Can Do for You...

06Jun10:33 amEST

Just Because They're Not Peacocking Doesn't Mean They're Not Bullish

It has been a quiet spring for agribusiness and chemical stocks, which are mostly housed in the XLB sector ETF. The U.S. Dollar rally has been one headwind for them, as the market's general knee-jerk reaction is to lay off most materials and commodity plays when the Dollar surges, with some exceptions here and there. But now that the Dollar is...

05Jun4:25 pmEST

Stock Market Recap 06/05/18 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

05Jun1:29 pmEST

No More Excuses for Dunkin' Donuts Not to Dominate

In addition to far more sensible price points and the general value proposition that consumers find in a Dunkin' Donuts versus Starbucks, the truth of the matter is that SBUX is having a terrible year all the way around. The latest news is that longtime leader and CEO Howard Schultz will be stepping down this month, perhaps to explore his...

05Jun10:56 amEST

Clean Living for Valeant; And They're Better for It

Lost in the shuffle of various headlines this winter and spring has been the steady comeback by Valeant Pharmaceuticals International, Inc. We profiled VRX about a month ago, and updated the daily chart, below, we can see the progress continues to take shape. Beyond organic growth, Valeant has plans to change its name to Bausch Health...

04Jun5:13 pmEST

Stock Market Recap 06/04/18 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

04Jun12:24 pmEST

Paint the Classic Picture

MINDBODY Inc., which provides cloud-based business management software for the wellness services industry, has been a favorite of ours for several years now. And with the recent surge in enterprise software stocks in general, MB becomes all the more attractive on all timeframes. On the updated MB daily timeframe, below, we have a classic...

04Jun10:34 amEST

Surviving the Storm

Beyond this morning's glaring weakness in the prominent domestic solar, First Solar (FSLR), we have been noting with Members for a while now that most solars were lagging the ascending kid on the solar block, Sunrun (RUN). Indeed, beyond FSLR, which is down 6.5% as I write this and slicing below its 200-day simple moving average, SEDG SPWR...

03Jun10:05 amEST

Sunday Matinée at Market Chess Cinemas

Collateral , not the current Netflix series, but the 2004 American neo-noir crime action thriller film, is a highly entertaining and worthy of viewing. The film was directed by Michael Mann, of Heat (1995) fame. And while Mann will never top Heat , Collateral ought not be disregarded. via YouTube: Vincent (Tom Cruise) is a cool,...

01Jun3:21 pmEST

That Nose is Like a Natural Canopy

One of our Members noted that Canopy Growth Corporation (CGC), formerly Tweed Marijuana Inc., is now trading off the Pink Sheets and on the NYSE . Alongside GWPH, I view CGC as a more liquid way to play "pot stocks," than merely speculating with illiquid trash on the Pink Sheets which could easily go to zero, and often does. Also note the...

31May1:44 pmEST

ASCO Not What Your Biotechs Can Do for You...

...ask what they can do for this market. With the Dow selling gaining steam today, and a Goldman Sachs headline about insider trading not helping the cause, more pressure seems to be building on tech and biotech to do the heavy lifting for bulls. There still remain fears about Italy, and now European banking titan DB is in the bears' crosshairs...